190 related articles for article (PubMed ID: 3858911)
21. Interactions of partial LSD analogs with behavioral disrupting effects of LSD and DMT in the rat.
Kovacic B; Wang Lu LJ; Ruffing D; Domino EF
Eur J Pharmacol; 1978 Jan; 47(1):37-44. PubMed ID: 271075
[TBL] [Abstract][Full Text] [Related]
22. Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.
Eckler JR; Chang-Fong J; Rabin RA; Smith C; Teitler M; Glennon RA; Winter JC
Pharmacol Biochem Behav; 2003 Jul; 75(4):845-52. PubMed ID: 12957227
[TBL] [Abstract][Full Text] [Related]
23. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
Hungen KV; Roberts S; Hill DF
Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
[TBL] [Abstract][Full Text] [Related]
24. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
Glennon RA; Young R; Rosecrans JA
Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
[TBL] [Abstract][Full Text] [Related]
25. A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus.
Helsley S; Fiorella D; Rabin RA; Winter JC
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):649-63. PubMed ID: 9682278
[TBL] [Abstract][Full Text] [Related]
26. Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat.
Kovacic B; Domino EF
J Pharmacol Exp Ther; 1976 Jun; 197(3):495-502. PubMed ID: 1064726
[TBL] [Abstract][Full Text] [Related]
27. The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.
Winter JC; Filipink RA; Timineri D; Helsley SE; Rabin RA
Pharmacol Biochem Behav; 2000 Jan; 65(1):75-82. PubMed ID: 10638639
[TBL] [Abstract][Full Text] [Related]
28. Effects of selected opioid agonists and antagonists on DMT- and LSD-25-induced disruption of food-rewarded bar pressing behavior in the rat.
Ruffing DM; Domino EF
Psychopharmacology (Berl); 1981; 75(3):226-30. PubMed ID: 6798611
[TBL] [Abstract][Full Text] [Related]
29. Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat.
Ruffing D; Kovacic B; Demetriou S; Domino EF
Psychopharmacology (Berl); 1979 Apr; 62(3):207-10. PubMed ID: 111285
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
[TBL] [Abstract][Full Text] [Related]
31. Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol.
Mittman SM; Geyer MA
Psychopharmacology (Berl); 1991; 105(1):69-76. PubMed ID: 1745714
[TBL] [Abstract][Full Text] [Related]
32. The effect of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM), pentobarbital and methaqualone on punished responding in control and 5,7-dihydroxytryptamine-treated rats.
Commissaris RL; Lyness WH; Rech RH
Pharmacol Biochem Behav; 1981 May; 14(5):617-23. PubMed ID: 7243840
[TBL] [Abstract][Full Text] [Related]
33. d-LSD binding to brain homogenates: possible relationship to serotonin receptors.
Bennett JL; Aghajanian GK
Life Sci; 1974 Dec; 15(11):1935-44. PubMed ID: 4620998
[No Abstract] [Full Text] [Related]
34. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
Titeler M; Lyon RA; Glennon RA
Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
[TBL] [Abstract][Full Text] [Related]
35. Neurological aspects of hallucinogenic drugs.
Logan WJ
Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
[No Abstract] [Full Text] [Related]
36. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.
Fiorella D; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 Oct; 121(3):347-56. PubMed ID: 8584617
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD.
Doat MM; Rabin RA; Winter JC
Pharmacol Biochem Behav; 2003 Feb; 74(3):713-21. PubMed ID: 12543238
[TBL] [Abstract][Full Text] [Related]
38. Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.
Mokler DJ; Rech RH
Pharmacol Biochem Behav; 1984 Aug; 21(2):281-7. PubMed ID: 6483939
[TBL] [Abstract][Full Text] [Related]
39. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.
Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB
Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890
[TBL] [Abstract][Full Text] [Related]
40. Opioid-hallucinogen interactions.
Domino EF
Pharmacol Biochem Behav; 1986 Feb; 24(2):401-5. PubMed ID: 3006089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
